Successful treatment of a Carbapenem-resistant Klebsiella pneumoniae carrying blaOXA-48, blaVIM-2, blaCMY-2 and blaSHV- with high dose combination of imipenem and amikacin

IDCases

Volumn 4, Issue , 2016, Pages 10-12

  Hajjej, Zied ^a   Gharsallah, Hedi ^a   Naija, Habiba ^a   Boutiba, Ilhem ^b   Labbene, Iheb ^a   Ferjani, Mustapha ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Bloodstream infections; Carbapenem resistant Klebsiella pneumoniae; Continuous venovenous hemodiafiltration

Indexed keywords

AMIKACIN; C REACTIVE PROTEIN; CARBAPENEMASE; COLISTIN; IMIPENEM; NORADRENALIN; PROCALCITONIN; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE REPORT; CENTRAL VENOUS CATHETER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMODIAFILTRATION; CORONARY ARTERY BYPASS GRAFT; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG MEGADOSE; DRUG WITHDRAWAL; EOSINOPHIL COUNT; HUMAN; HYPERTENSION; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE REPLACEMENT; NEPHROTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPTIC SHOCK; SEQUENCE ANALYSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84959036630     PISSN: 22142509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idcr.2016.01.003     Document Type: Article

References (10)

1. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; 21st informational supplement 2011, Clinical and Laboratory Standards Institute, Wayne, PA.
2. Dallenne C., Da Costa A., Decre D., Favier C., Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65:490-495.
3. Eckert C., Gautier V., Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 2006, 57:14-23.
4. Pérez-Pérez F., Hanson N. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
5. Bratu S., Landman D., Haag R., Recco R., Eramo A. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005, 165:1430-1435.
6. Gasink L.B., Edelstein P.H., Lautenbach E., Fishman N.O. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009, 30:1180-1185.
7. Qureshi Z.A., Paterson D.L., Potoski B.A., Kilayko M.C., Sandovsky G. Treatment outcome of bacteremia due to KPC producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012, 56:2108-2113.
8. Tumbarello M., Viale P., Viscoli C., Trecarichi E.M., Tumietto F., Marchese A. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012, 55:943-950.
9. Hirsch E.B., Tam V.H. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug resistant infection. J Antimicrob Chemother 2010, 65:1119-1125.
10. Rea R.S., Capitano B., Bies R., Bigos K.L., Smith R., Lee H. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit 2008, 30:674-681.